1496 related articles for article (PubMed ID: 27277809)
21. 5-(3,4-Difluorophenyl)-3-(6-methylpyridin-3-yl)-1,2,4-oxadiazole (DDO-7263), a novel Nrf2 activator targeting brain tissue, protects against MPTP-induced subacute Parkinson's disease in mice by inhibiting the NLRP3 inflammasome and protects PC12 cells against oxidative stress.
Xu LL; Wu YF; Yan F; Li CC; Dai Z; You QD; Jiang ZY; Di B
Free Radic Biol Med; 2019 Apr; 134():288-303. PubMed ID: 30615919
[TBL] [Abstract][Full Text] [Related]
22. Gastrodin prevents motor deficits and oxidative stress in the MPTP mouse model of Parkinson's disease: involvement of ERK1/2-Nrf2 signaling pathway.
Wang XL; Xing GH; Hong B; Li XM; Zou Y; Zhang XJ; Dong MX
Life Sci; 2014 Oct; 114(2):77-85. PubMed ID: 25132361
[TBL] [Abstract][Full Text] [Related]
23. L-F001, a Multifunction ROCK Inhibitor Prevents 6-OHDA Induced Cell Death Through Activating Akt/GSK-3beta and Nrf2/HO-1 Signaling Pathway in PC12 Cells and Attenuates MPTP-Induced Dopamine Neuron Toxicity in Mice.
Luo L; Chen J; Su D; Chen M; Luo B; Pi R; Wang L; Shen W; Wang R
Neurochem Res; 2017 Feb; 42(2):615-624. PubMed ID: 28078613
[TBL] [Abstract][Full Text] [Related]
24. Gintonin Mitigates MPTP-Induced Loss of Nigrostriatal Dopaminergic Neurons and Accumulation of α-Synuclein via the Nrf2/HO-1 Pathway.
Jo MG; Ikram M; Jo MH; Yoo L; Chung KC; Nah SY; Hwang H; Rhim H; Kim MO
Mol Neurobiol; 2019 Jan; 56(1):39-55. PubMed ID: 29675576
[TBL] [Abstract][Full Text] [Related]
25. Pinostrobin Exerts Neuroprotective Actions in Neurotoxin-Induced Parkinson's Disease Models through Nrf2 Induction.
Li C; Tang B; Feng Y; Tang F; Pui-Man Hoi M; Su Z; Ming-Yuen Lee S
J Agric Food Chem; 2018 Aug; 66(31):8307-8318. PubMed ID: 29961319
[TBL] [Abstract][Full Text] [Related]
26. Neuroprotective effects of protocatechuic aldehyde through PLK2/p-GSK3β/Nrf2 signaling pathway in both
Guo C; Zhu J; Wang J; Duan J; Ma S; Yin Y; Quan W; Zhang W; Guan Y; Ding Y; Wen A; Zhang Y
Aging (Albany NY); 2019 Nov; 11(21):9424-9441. PubMed ID: 31697645
[TBL] [Abstract][Full Text] [Related]
27. Comparison of Neuroprotective Effects of Monomethylfumarate to the Sigma 1 Receptor Ligand (+)-Pentazocine in a Murine Model of Retinitis Pigmentosa.
Xiao H; Wang J; Saul A; Smith SB
Invest Ophthalmol Vis Sci; 2020 Mar; 61(3):5. PubMed ID: 32150247
[TBL] [Abstract][Full Text] [Related]
28. Pharmacological targeting of the transcription factor Nrf2 at the basal ganglia provides disease modifying therapy for experimental parkinsonism.
Jazwa A; Rojo AI; Innamorato NG; Hesse M; Fernández-Ruiz J; Cuadrado A
Antioxid Redox Signal; 2011 Jun; 14(12):2347-60. PubMed ID: 21254817
[TBL] [Abstract][Full Text] [Related]
29. Novel flavonoid 1,3,4-oxadiazole derivatives ameliorate MPTP-induced Parkinson's disease via Nrf2/NF-κB signaling pathway.
Meng HW; Shen ZB; Meng XS; Leng-Wei ; Yin ZQ; Wang XR; Zou TF; Liu ZG; Wang TX; Zhang S; Chen YL; Yang XX; Li QS; Duan YJ
Bioorg Chem; 2023 Sep; 138():106654. PubMed ID: 37300959
[TBL] [Abstract][Full Text] [Related]
30. Effects of the root bark of Paeonia suffruticosa on mitochondria-mediated neuroprotection in an MPTP-induced model of Parkinson's disease.
Kim HG; Park G; Piao Y; Kang MS; Pak YK; Hong SP; Oh MS
Food Chem Toxicol; 2014 Mar; 65():293-300. PubMed ID: 24389454
[TBL] [Abstract][Full Text] [Related]
31. Artemisinin protects dopaminergic neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in a mouse model of Parkinson's disease.
Lim HS; Park G
Biomed Pharmacother; 2024 Jan; 170():115972. PubMed ID: 38056239
[TBL] [Abstract][Full Text] [Related]
32. S-allyl cysteine protects against MPTP-induced striatal and nigral oxidative neurotoxicity in mice: participation of Nrf2.
García E; Santana-Martínez R; Silva-Islas CA; Colín-González AL; Galván-Arzate S; Heras Y; Maldonado PD; Sotelo J; Santamaría A
Free Radic Res; 2014 Feb; 48(2):159-67. PubMed ID: 24147739
[TBL] [Abstract][Full Text] [Related]
33. Licochalcone E activates Nrf2/antioxidant response element signaling pathway in both neuronal and microglial cells: therapeutic relevance to neurodegenerative disease.
Kim SS; Lim J; Bang Y; Gal J; Lee SU; Cho YC; Yoon G; Kang BY; Cheon SH; Choi HJ
J Nutr Biochem; 2012 Oct; 23(10):1314-23. PubMed ID: 22227268
[TBL] [Abstract][Full Text] [Related]
34. Nrf2 activation by tauroursodeoxycholic acid in experimental models of Parkinson's disease.
Moreira S; Fonseca I; Nunes MJ; Rosa A; Lemos L; Rodrigues E; Carvalho AN; Outeiro TF; Rodrigues CMP; Gama MJ; Castro-Caldas M
Exp Neurol; 2017 Sep; 295():77-87. PubMed ID: 28552716
[TBL] [Abstract][Full Text] [Related]
35. S-allyl cysteine activates the Nrf2-dependent antioxidant response and protects neurons against ischemic injury in vitro and in vivo.
Shi H; Jing X; Wei X; Perez RG; Ren M; Zhang X; Lou H
J Neurochem; 2015 Apr; 133(2):298-308. PubMed ID: 25393425
[TBL] [Abstract][Full Text] [Related]
36. A Novel Compound ITC-3 Activates the Nrf2 Signaling and Provides Neuroprotection in Parkinson's Disease Models.
Lee JA; Son HJ; Park KD; Han SH; Shin N; Kim JH; Kim HR; Kim DJ; Hwang O
Neurotox Res; 2015 Nov; 28(4):332-45. PubMed ID: 26233727
[TBL] [Abstract][Full Text] [Related]
37. Dimethylfumarate attenuates renal fibrosis via NF-E2-related factor 2-mediated inhibition of transforming growth factor-β/Smad signaling.
Oh CJ; Kim JY; Choi YK; Kim HJ; Jeong JY; Bae KH; Park KG; Lee IK
PLoS One; 2012; 7(10):e45870. PubMed ID: 23056222
[TBL] [Abstract][Full Text] [Related]
38. Neuroprotective effect of fasudil on inflammation through PI3K/Akt and Wnt/β-catenin dependent pathways in a mice model of Parkinson's disease.
Zhao Y; Zhang Q; Xi J; Xiao B; Li Y; Ma C
Int J Clin Exp Pathol; 2015; 8(3):2354-64. PubMed ID: 26045742
[TBL] [Abstract][Full Text] [Related]
39. Impairment of Nrf2- and Nitrergic-Mediated Gastrointestinal Motility in an MPTP Mouse Model of Parkinson's Disease.
Sampath C; Kalpana R; Ansah T; Charlton C; Hale A; Channon KM; Srinivasan S; Gangula PR
Dig Dis Sci; 2019 Dec; 64(12):3502-3517. PubMed ID: 31187328
[TBL] [Abstract][Full Text] [Related]
40. Multitarget intervention of Fasudil in the neuroprotection of dopaminergic neurons in MPTP-mouse model of Parkinson's disease.
Zhao YF; Zhang Q; Xi JY; Li YH; Ma CG; Xiao BG
J Neurol Sci; 2015; 353(1-2):28-37. PubMed ID: 25908255
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
